Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (Nature’s Sunshine), a leading natural health and wellness company of high-quality herbal and nutritional products, reported financial results for the second quarter ended June 30, 2022.
Second Quarter 2022 Financial Summary vs. Same Year-Ago Quarter
Net sales were $104.2 million compared to $109.0 million.
GAAP net income was $1.0 million, or $0.03 per diluted share, compared to $6.8 million, or $0.32 per diluted share.
Adjusted EBITDA was $9.0 million compared to $13.4 million.
Management Commentary
“The challenges facing our world certainly remained in the second quarter,”
said Terrence Moorehead, CEO of Nature’s Sunshine.
“The devastating war in Ukraine, rampant inflation, supply chain pressures, and the lingering impact of COVID-19 hampered our vision to share the healing power of nature with everyone.
Despite the headwinds, our revenue was flat on a constant currency basis, driven by continued rapid growth in Asia and mitigated losses in Europe. We believe these outcomes illuminate the resilience of our brand, the power of our vision, and the advantages of our global presence.
“As we look to the remainder of the year, we recognize the volatility and uncertainty of the operating environment.
However, we will continue to invest in our five global growth strategies and support our partners